Broadening the antibody response of intradermal influenza vaccine by prior topical imiquimod, a Toll-like receptor 7 agonist, may enhance the vaccine effectiveness against these A(H3N2) viruses with antigenic changes35. The gene discussed is TLR7; the disease is influenza.